Drug May Reduce Probability of HIV Leading to AIDS : SCIENCE FILE / An exploration of issues and trends affecting science, medicine and the environment
From Times staff and wire reports
The drug Rescriptor may reduce the probability of HIV patients developing AIDS, according to the Swedish-American drug company Pharmacia & Upjohn.
Rescriptor, also known under its scientific name delavirdine, may reduce the amount of virus circulating in the bloodstream by at least 68% for as long as 60 weeks. The company said it may be able to seek dispensation from the Food and Drug Administration to rush the drug into production.
